Riskpilot← Back to searchSign inGet full accessSEMYAMED AS
ASActiveOrg 924685476Kavlebruvegen 11, 2312 OttestadGeneral medical practice activities · NACE 8621Est. 20201 employees
Revenue 2025
NOK 3,7M
+1% vs 2024
EBITDA margin
41.3%
+2% vs 2024
Equity ratio
1.5%
Financial strength
Net profit 2025
NOK 1,1M
+9% vs 2024
| Revenue | NOK 3,7M | +1% |
| EBITDA | NOK 1,5M | +2% |
| Net profit | NOK 1,1M | +9% |
| Total assets | NOK 2,1M | -1% |
| Equity | NOK 31K | +0% |
| Employees | 1 | — |
Legal name
SEMYAMED AS
Org number
924685476
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
13. mars 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmennmedisinsk behandling, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer, sakkyndige oppdrag og annen konsulentvirksomhet.
Address
Kavlebruvegen 11, 2312 Ottestad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 984 | 3 290 | 3 651 | 3 678 | 3 724 |
| Staff expenses | −876 | −970 | −1 138 | −1 133 | −1 113 |
| EBITDA | 1 195 | 1 212 | 1 428 | 1 514 | 1 538 |
| Depreciation & amort. | −127 | −225 | −225 | −224 | −148 |
| EBIT | 1 069 | 987 | 1 203 | 1 290 | 1 390 |
| Net financials | −3 | −20 | −32 | −20 | −8 |
| Profit before tax | 1 065 | 967 | 1 170 | 1 270 | 1 382 |
| Tax | 234 | 213 | 257 | 280 | 304 |
| Net profit | 831 | 754 | 913 | 990 | 1 078 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 656 | 1 996 | 2 112 | 2 130 | 2 098 |
| Equity | 1 267 | 30 | 33 | 31 | 31 |
| Long-term debt | 1 029 | 636 | 535 | 439 | 338 |
| Short-term debt | 360 | 1 331 | 1 543 | 1 661 | 1 729 |
| Total debt | 1 388 | 1 966 | 2 079 | 2 099 | 2 068 |
EBITDA margin
41.3%
This company
15.8%
Market median
+161% vs market
20212025
Equity ratio
1.5%
This company
38.2%
Market median
-96% vs market
20212025
Return on equity
3511.1%
This company
18.4%
Market median
+18982% vs market
20212025
Net profit margin
28.9%
This company
8.1%
Market median
+257% vs market
20212025
Asset turnover
1.77×
This company
1.12×
Market median
+58% vs market
20212025
Debt / equity
67.36×
This company
0.62×
Market median
-10765% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Semya Kapital As
SEMYAMED AS Board members of SEMYAMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Berit Arner Ådnanes | Board of Directors | 0 companies |
| Oddvar Ådnanes | Chairman | 0 companies |